Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03193567
PHASE1

Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Sponsor: Ruijin Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study to preliminarily evaluate the safety and efficacy of High Efficient Killing Cell Therapy for refractory and advanced non-small cell lung cancer

Official title: Phase I Study of High Efficient Killing Cell Therapy for Advanced Non Small Cell Lung Cancer

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2017-09-14

Completion Date

2025-05-01

Last Updated

2024-11-19

Healthy Volunteers

No

Interventions

BIOLOGICAL

HEKT cell

3 cycles of HEKT cell treatment

Locations (1)

Ruijin Hospital

Shanghai, China